Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 431

1.

Prevalence of human T-cell lymphotropic virus infections in Germany.

Schätzl H, Schwarzfischer G, Rose D, Gathof B, Weise W, Deinhardt F, Von der Helm K.

J Med Virol. 1994 Jun;43(2):159-60.

PMID:
7916035
2.

[A new variant of the simian T-lymphotropic retrovirus type I (STLV-IF) in the Sukhumi colony of hamadryas baboons].

Chikobaeva MG, Schatzl H, Rose D, Bush U, Iakovleva LA, Deinhardt F, Helm K, Lapin BA.

Vopr Virusol. 1993 Nov-Dec;38(6):249-53. Russian.

PMID:
7905690
3.

Production of human cloned antibodies specific for hepatitis D virus-encoded small and large protein.

Liu F, Roggendorf M, Rasshofer R, Zachoval R, Deinhardt F.

J Hepatol. 1993 Sep;19(2):222-7.

PMID:
7507955
4.

The immune response to different doses of inactivated hepatitis A vaccine.

Jilg W, Bittner R, Schätzl H, Rasshofer R, Schmidt M, Deinhardt F.

J Hepatol. 1993;18 Suppl 2:S38-40.

PMID:
8182271
5.

Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.

von Brunn A, Brand M, Reichhuber C, Morys-Wortmann C, Deinhardt F, Schödel F.

Vaccine. 1993;11(8):817-24.

PMID:
7689283
6.

The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.

Rieber EP, Federle C, Reiter C, Krauss S, Gürtler L, Eberle J, Deinhardt F, Riethmüller G.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10792-6.

7.

Heat stability of parvovirus B19: kinetics of inactivation.

Schwarz TF, Serke S, Von Brunn A, Hottenträger B, Huhn D, Deinhardt F, Roggendorf M.

Zentralbl Bakteriol. 1992 Jul;277(2):219-23.

PMID:
1520981
8.

Virus infections: strategies of prevention.

Deinhardt F.

Behring Inst Mitt. 1992 Apr;(91):28-37. Review.

PMID:
1524569
9.

[The prevention of nosocomial infections after an accidental needle-stick injury].

Bader L, Gürtler L, Eberle J, Deinhardt F.

Dtsch Med Wochenschr. 1992 Mar 27;117(13):515-7. German. No abstract available.

PMID:
1551378
10.

Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood.

Schwarz TF, Serke S, Hottenträger B, von Brunn A, Baurmann H, Kirsch A, Stolz W, Huhn D, Deinhardt F, Roggendorf M.

J Virol. 1992 Feb;66(2):1273-6.

11.

Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzymed-linked immunosorbent assay.

Schlipköter U, Gladziwa U, Cholmakov K, Weise A, Rasshofer R, Lorbeer B, Luz N, Deinhardt F, Roggendorf M.

Med Microbiol Immunol. 1992;181(3):173-80.

PMID:
1381808
12.

Vaccination against hepatitis A: comparison of different short-term immunization schedules.

Jilg W, Bittner R, Bock HL, Clemens R, Schätzl H, Schmidt M, André FE, Deinhardt F.

Vaccine. 1992;10 Suppl 1:S126-8.

PMID:
1335642
13.

Hepatitis A vaccination: schedule for accelerated immunization.

Müller R, Chriske H, Deinhardt F, Jilg J, Theilmann L, Hess G, Hofmann F, Hopf U, Stickl H, Maiwald H, et al.

Vaccine. 1992;10 Suppl 1:S124-5.

PMID:
1335641
14.

Prevention of viral hepatitis A: past, present and future.

Deinhardt F.

Vaccine. 1992;10 Suppl 1:S10-4. Review.

PMID:
1335635
15.

Detection and characterization of hepatitis C virus sequence in the serum of a patient with chronic HCV infection.

Schreier E, Fuchs K, Höhne M, Motz M, Zachoval R, Esteban J, Dittmann S, Deinhardt F, Roggendorf M.

Arch Virol Suppl. 1992;4:179-83.

PMID:
1333321
16.

Detection and characterization of T-cell leukemia virus-like proviral sequences in PBL and tissues of baboons by PCR.

Schatzl H, Yakovleva L, Lapin B, Rose D, Inzhiia L, Gaedigk-Nitschko K, Deinhardt F, von der Helm K.

Leukemia. 1992;6 Suppl 3:158S-160S.

PMID:
1318468
17.

Long-term persistence of hepatitis C virus antibodies in a single source outbreak.

Dittmann S, Roggendorf M, Dürkop J, Wiese M, Lorbeer B, Deinhardt F.

J Hepatol. 1991 Nov;13(3):323-7.

PMID:
1725527
18.

[Obstructive respiratory tract diseases in children and Parvovirus B19 infections].

Wiersbitzky S, Schwarz TF, Bruns R, Ballke EH, Wiersbitzky H, Jäger G, Hottenträger B, Roggendorf M, Deinhardt F.

Kinderarztl Prax. 1991 Oct;59(10):299-301. German.

PMID:
1745035
19.

[Blood picture findings in children with Parvovirus B19 infections (fifth disease/erythema infectiosum)].

Wiersbitzky S, Schwarz TF, Ladstätter L, Bruns R, Abel E, Deinhardt F, Roggendorf M, Paul W, Jäger G, Hottenträger B, et al.

Kinderarztl Prax. 1991 Oct;59(10):302-6. German.

PMID:
1660551
20.

[The blood picture in exanthema subitum (Zahorsky)/ critical 3-day fever-exanthema in young children].

Wiersbitzky S, Abel E, Bruns R, Eberle J, Ladstätter L, Wiersbitzky H, Paul W, Deinhardt F.

Kinderarztl Prax. 1991 Sep;59(9):258-61. German.

PMID:
1658424
21.

Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization.

Serke S, Schwarz TF, Baurmann H, Kirsch A, Hottenträger B, Von Brunn A, Roggendorf M, Huhn D, Deinhardt F.

Br J Haematol. 1991 Sep;79(1):6-13.

PMID:
1654995
22.

Characterization of nucleotide sequences from European hepatitis C virus isolates.

Fuchs K, Motz M, Schreier E, Zachoval R, Deinhardt F, Roggendorf M.

Gene. 1991 Jul 22;103(2):163-9.

PMID:
1653756
23.

Acute obstructive respiratory diseases in infants and children associated with parvovirus B19 infection.

Wiersbitzky S, Schwarz TF, Bruns R, Ballke EH, Roggendorf M, Wiersbitzky H, Deinhardt F.

Infection. 1991 Jul-Aug;19(4):252. No abstract available.

PMID:
1917040
24.

[Seroprevalence of antibodies to human herpesvirus 6 (exanthema subitum; critical 3-day fever-exanthema in young children) in the population of Northern Germany].

Wiersbitzky S, Eberle J, Bruns R, Weidemeier H, Bittner S, Dorn U, Frick G, Abel E, Ladstätter L, Deinhardt F.

Kinderarztl Prax. 1991 Jun;59(6):170-3. German.

PMID:
1656131
25.

[HIV and nervous system manifestations: a review].

Riedel RR, Bader L, Naber D, Gürtler L, Günther W, Deinhardt F, Hippius H.

Fortschr Neurol Psychiatr. 1991 Mar;59(3):69-80. Review. German.

PMID:
2050314
26.

[HTLV-I antibody screening of blood donors].

Schwarzfischer G, Schätzl H, Bäcker U, Weise W, von der Helm K, Deinhardt F.

Beitr Infusionsther. 1991;28:29-31. German.

PMID:
1725641
27.

(K15R M52E) aprotinin is a weak Kunitz-type inhibitor of HIV-1 replication in H9 cells.

Auerswald EA, Schubert A, Dolinar M, Gürtler L, Deinhardt F.

Biomed Biochim Acta. 1991;50(4-6):697-700.

PMID:
1724906
28.

Prevalence of antibodies against hepatitis A virus, hepatitis B virus, and Treponema pallidum in Mauritius.

Schwarz TF, Kam CC, Min GL, Jilg W, Wilske B, Gürtler L, Deinhardt F.

Scand J Infect Dis. 1991;23(5):535-41.

PMID:
1662829
29.

Expression of human immunodeficiency virus type 1 gag gene using genetically engineered herpes simplex virus type 1 recombinants.

Rösen-Wolff A, Raab K, Zöller L, Darai G, Eberle J, Deinhardt F.

Virus Genes. 1990 Dec;4(4):325-37.

PMID:
1962977
30.

Immunoglobulins in the prophylaxis of parvovirus B19 infection.

Schwarz TF, Roggendorf M, Hottenträger B, Modrow S, Deinhardt F, Middeldorp J.

J Infect Dis. 1990 Nov;162(5):1214. No abstract available.

PMID:
2172397
31.

Monoclonal CD4 antibodies after accidental HIV infection.

Rieber EP, Reiter C, Gürtler L, Deinhardt F, Riethmüller G.

Lancet. 1990 Oct 20;336(8721):1007-8. No abstract available. Erratum in: Lancet 1990 Nov 17;336(8725):1266.

PMID:
1976987
32.

[Inoculation failure following hepatitis B vaccination. The effect of additional vaccinations].

Jilg W, Schmidt M, Deinhardt F.

Dtsch Med Wochenschr. 1990 Oct 12;115(41):1545-8. German.

PMID:
2209442
33.

[New aspects in HIV diagnosis].

Gürtler L, Eberle J, Bader L, Deinhardt F.

Internist (Berl). 1990 Sep;31(9):587-92. Review. German. No abstract available.

PMID:
2242983
34.

Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response.

Gauss-Müller V, Zhou MQ, von der Helm K, Deinhardt F.

J Med Virol. 1990 Aug;31(4):277-83.

PMID:
2176673
35.

Vaccines, cells, and nucleic acids: conclusions.

Zuckerman AJ, Deinhardt F.

J Med Virol. 1990 May;31(1):2-4. No abstract available.

PMID:
2376725
36.

[Seroprevalence of human parvovirus B 19 antibodies (Sticker's disease/erythema infectiosum) in the DRG population].

Wiersbitzky S, Schwarz TF, Bruns R, Jäger G, Bittner S, Weidemann H, Deinhardt F, Hottenträger B, Abel E, Ladstätter L, et al.

Kinderarztl Prax. 1990 Apr;58(4):185-9. German.

PMID:
2164118
37.

Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2.

Ayres L, Avillez F, Garcia-Benito A, Deinhardt F, Gürtler L, Denis F, Léonard G, Ranger S, Grob P, Joller-Jemelka H, et al.

AIDS. 1990 Feb;4(2):131-8.

PMID:
2183814
38.

[Parvovirus B19 infections in Germany 1987-1988].

Schwarz TF, Jäger G, Schlipköter UA, Wiersbitzky S, Tiller FW, Hottenträger B, Deinhardt F, Roggendorf M.

Offentl Gesundheitswes. 1990 Feb;52(2):53-7. German.

PMID:
2158028
39.

Serology and interferon production during the early phase of acute hepatitis A.

Zachoval R, Kroener M, Brommer M, Deinhardt F.

J Infect Dis. 1990 Feb;161(2):353-4. No abstract available.

PMID:
1688907
40.

Decline of anti-HBs after hepatitis B vaccination and timing of revaccination.

Jilg W, Schmidt M, Deinhardt F.

Lancet. 1990 Jan 20;335(8682):173-4. No abstract available.

PMID:
1967468
41.

[Vaccines, cells and nucleic acids].

Zuckerman AJ, Deinhardt F.

Bull World Health Organ. 1990;68(3):293-5. French. No abstract available.

42.

Vaccines, cells and nucleic acids.

Zuckerman AJ, Deinhardt F.

Bull World Health Organ. 1990;68(2):139-41. No abstract available.

43.

Transmission of hepatitis C virus (HCV) from a haemodialysis patient to a medical staff member.

Schlipköter U, Roggendorf M, Cholmakow K, Weise A, Deinhardt F.

Scand J Infect Dis. 1990;22(6):757-8. No abstract available.

PMID:
2126645
44.

Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

Hopf U, Möller B, Küther D, Stemerowicz R, Lobeck H, Lüdtke-Handjery A, Walter E, Blum HE, Roggendorf M, Deinhardt F.

J Hepatol. 1990 Jan;10(1):69-76.

PMID:
2106548
45.

Carbohydrate components of human immunodeficiency viruses type I and II.

Schumacher U, Eberle J, Wolf H, Welsch U, Ziegler-Heitbrook HW, Gürtler L, Deinhardt F.

Acta Histochem Suppl. 1990;40:85-9.

PMID:
2091051
46.

Endogenous interferon (IFN) in patients with acute hepatitis B.

Boron-Kaczmarska A, Zachoval R, Zachoval V, Deinhardt F.

Acta Med Hung. 1990;47(1-2):77-80.

PMID:
1704122
47.

[Hepatitis C antibodies in non-A, non-B hepatitis patients and members of HIV risk groups (pilot study)].

Kühnl P, Roggendorf M, Stangel W, Seidl S, Laufs R, Sibrowski W, Bornhövd K, Polywka S, Kalmar G, Deinhardt F, et al.

Beitr Infusionsther. 1990;26:30-2. German.

PMID:
1703858
48.

[Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis].

Kühnl P, Roggendorf M, Sibrowski W, Deinhardt F, Laufs R, Bornhövd K, Kalmar G, Seidl S, Böhm BO.

Beitr Infusionsther. 1990;26:27-9. German.

PMID:
1703848
49.

Vaccination against hepatitis B: comparison of three different vaccination schedules.

Jilg W, Schmidt M, Deinhardt F.

J Infect Dis. 1989 Nov;160(5):766-9.

PMID:
2530289
50.

Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs.

Schramm W, Roggendorf M, Rommel F, Kammerer R, Pohlmann H, Rasshofer R, Gürtler L, Deinhardt F.

Blut. 1989 Oct;59(4):390-2.

PMID:
2506955

Supplemental Content

Loading ...
Support Center